Nanjing King-Friend Biochemical Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nanjing King-Friend Biochemical Pharmaceutical Co Ltd with three other
companies in this sector in China:
Tianjin Ringpu Bio-Technology Co Ltd
sales of 1.05 billion Chinese Renmimbi [US$152.74 million]
of which 56%
was Veterinary Biological Products),
Beijing SL Pharmaceutical Co Ltd
(1.24 billion Chinese Renmimbi [US$181.14 million]
of which 98%
was Pharmaceuticals Industry), and
Shenzhen Kangtai Biological Products Co Ltd
(1.16 billion Chinese Renmimbi [US$169.35 million]
of which 100%
was Biological products).